Literature DB >> 1593031

Midterm outcome of patients with asymptomatic restenosis after coronary balloon angioplasty.

R A Hernández1, C Macaya, A Iñiguez, F Alfonso, J Goicolea, A Fernandez-Ortiz, P Zarco.   

Abstract

Although many patients with restenosis after balloon coronary angioplasty have recurrence of angina, others remain asymptomatic. To assess the clinical implications of asymptomatic coronary restenosis, we analyzed clinical and angiographic characteristics of 277 consecutive patients with restenosis, 133 (48%) of whom were asymptomatic (group I) and 144 (52%) symptomatic (group II). Restenosis was documented 6 to 9 months after the index procedure, or earlier if angina recurred, and was defined as a greater than 50% lumen narrowing (visual estimation). Group I (asymptomatic group) included fewer female (9% vs. 18%, p less than 0.05) and hypertensive patients (38% vs. 56%, p less than 0.005) and more patients with a previous myocardial infarction (48% vs. 28%, p less than 0.05) and single-vessel disease (67% vs. 55%, p less than 0.05). Before angioplasty, symptoms had lasted for a shorter period (10 +/- 25 vs. 23 +/- 42 months, p less than 0.001), ischemia after a recent infarction was a more frequent indication (21% vs. 10%, p less than 0.05) and total revascularization more frequently obtained (74% vs. 63%, p less than 0.05) in group I than in group II patients. Only a normal blood pressure, previous myocardial infarction, single-vessel disease and a shorter duration of symptoms were independent correlates of asymptomatic restenosis. No differences were found in stenosis severity before angioplasty (90% in both groups) or after angioplasty (22% +/- 12% vs. 24% +/- 16%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1593031     DOI: 10.1016/0735-1097(92)90594-d

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Role of myocardial perfusion imaging after coronary revascularization in symptom-free patients: are low-risk patients really low?

Authors:  Dominick Joseph Angiolillo; Alessandro Giordano
Journal:  J Nucl Cardiol       Date:  2002 Sep-Oct       Impact factor: 5.952

2.  Diagnostic value of myocardial SPECT to detect in-stent restenosis after drug-eluting stent implantation.

Authors:  Hyo Eun Park; Bon-Kwon Koo; Kyung-Woo Park; Jin Chul Paeng; Hae-Young Lee; Hyun-Jae Kang; Hyo-Soo Kim
Journal:  Int J Cardiovasc Imaging       Date:  2012-03-07       Impact factor: 2.357

3.  Treatment of coronary in-stent restenosis-evidence for universal recommendation?

Authors:  Ibrahim Akin; Christoph A Nienaber
Journal:  J Thorac Dis       Date:  2015-10       Impact factor: 2.895

4.  Cobalt-chromium stents in long lesions of large vessels: clinical and angiographic results.

Authors:  Iñigo Lozano; Carlos Cuellas; Pablo Avanzas; Armando Pérez de Prado; Concepción Suárez; Juan Rondan; Daehyun Lee; Jesus M de la Hera; Felipe Fernández; César Morís
Journal:  Tex Heart Inst J       Date:  2011

5.  Detection of patients with restenosis after PTCA by dipyridamole-atropine-stress-echocardiography.

Authors:  A W Scherhag; S Pfleger; A B Schreckenberger; J Grüttner; W Voelker; U Staedt; D L Heene
Journal:  Int J Card Imaging       Date:  1997-04

Review 6.  Current Management of In-Stent Restenosis.

Authors:  Ae Young Her; Eun Seok Shin
Journal:  Korean Circ J       Date:  2018-05       Impact factor: 3.243

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.